key: cord-0997297-sonxopa0
authors: Liu, Jiaye; Liao, Xuejiao; Qian, Shen; Yuan, Jing; Wang, Fuxiang; Liu, Yingxia; Wang, Zhaoqin; Wang, Fu-Sheng; Liu, Lei; Zhang, Zheng
title: Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020
date: 2020-06-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2606.200239
sha: 1b5f6e2f82702ded275a078990c34dec6af396dd
doc_id: 997297
cord_uid: sonxopa0

Since early January 2020, after the outbreak of coronavirus infection in Wuhan, China, ≈365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed.

China (1) . Although China launched an emergency response early in the outbreak, the infection rapidly spread to metropolitan areas in China and around the world. The growing number of cases suggests that the epidemic has continued to spread. Several research articles have reported the epidemiologic characteristics of the outbreak in Wuhan and Hubei Province (1) (2) (3) (4) ; however, to our knowledge, an analysis of the epidemic in metropolis areas around Wuhan has not yet been reported. To predict the epidemic trend and guide control measures, especially in similar metropolitan areas, outbreak investigations are needed.

Shenzhen, a modern and international metropolitan city, is located in southern China (Appendix Figure 1 , https://wwwnc.cdc.gov/EID/ article/26/6/20-0239-App1.pdf) and has a population of 13 million persons, among which >1 million are from Hubei Province and >70,000 from Wuhan. After the first cluster of COVID-19 cases was confirmed in Shenzhen in early January 2020 (W.J. Guan et al., unpub. data, https://doi.org/10.1101/2020.02 .06.20020974), other cases spread within the city, involving all districts. To summarize the epidemiologic characteristics and provide updated information to aid in the development of control measures, we analyzed data for the first 365 laboratory-confirmed cases of COVID-19 in Shenzhen.

In early January 2020, a total of 24 days after the index COVID-19 case occurred in Wuhan, a familial cluster of COVID-19 case-patients who had traveled to Wuhan from December 29, 2019, through January 4, 2020, was identified in Shenzhen (5) . Subsequently, more cases in the city were reported. Analysis of spatiotemporal dynamics indicated that the infection spread more broadly throughout the city (Figure; Appendix Figure 2 ). Since January 17, infections increased substantially, peaking January 22-30. The decline since January 30 is probably the result of underascertainment of cases with recent onset and delayed identification or reporting (Figure) .

Evaluation of the potential risk for local transmission will help determine whether patients with newly reported cases had definite exposure, defined by either having had definite contact with confirmed casepatients or having traveled to Wuhan or other cities in Hubei, or both, over the past 14 days. Overall, most (91%) cases that we report had definite exposure. On January 14, the first infected case-patient without definite exposure was reported in Shenzhen. Since January 20, growing numbers of cases without definite exposure were observed. Compared with the proportion before January 24, the proportion of case-patients without definite exposure was much higher from

Since early January 2020, after the outbreak of coronavirus infection in Wuhan, China, ≈365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed.

January 25 through February 5 (11% vs. 6%; p<0.001) and increased to 36% (12/33) on both January 31 and February 5. These data suggest an increasing risk for community transmission (Table 1 ; Figure) . We analyzed the clinical and epidemiologic characteristics of 365 persons with laboratory-confirmed cases in Shenzhen. The median case-patient age was 46 (range 1-86) years; 182 (50%) case-patients were male. To investigate the shift of the epidemic, we compared characteristics of case-patients during 2 periods: before January 24 (the Chinese Spring Festival) and after January 25 (until February 5). Because of delays between Figure. Onset of illness timeline for the first 365 confirmed COVID-19 case-patients in Shenzhen, China. The decline in incidence after January 30, 2020, probably resulted from delays in diagnosis and laboratory confirmation. All cases in this curve were confirmed. Hospital-based surveillance began January 8, 2020, for patients with suspected cases, defined by having a history of travel to Wuhan within the past 14 days, fever, and radiographic evidence of viral pneumonitis. PCR confirmation began January 13, 2020, and subsequently expanded the criteria for patients with suspected cases, defined by having typical clinical manifestations of COVID-19 and excluding infection caused by type A and B influenza and respiratory syncytial virus, regardless of travel history. NCIP, novel coronavirus-infected pneumonia (now called COVID-19). infection to illness onset or illness onset to confirmation, the following comparisons between the 2 periods might be biased because of misclassification.

We found a sharply increasing proportion of infected children (from 2% before January 24 to 13% for January 25-February 5; p<0.001), implying that increased exposure for children and intrafamily transmission might contribute substantially to the epidemic. Although substantially higher after January 25, 2020, the proportion of infected children in our study before January 24, 2020, was similar to the proportions reported by Li We explored the incubation periods for 58 casepatients with definite exposure and detailed investigation information. The estimated mean incubation periods were 6.1 (range 1-16) days among 33 casepatients who had had close contact with symptomatic confirmed case-patients and 6.0 (range 1-15) days among 25 case-patients who had traveled to Wuhan and stayed <1 day over the previous 3 weeks (Table  2; Appendix Table 1 ). Estimated incubation periods were consistent with those previously reported (1). We analyzed the characteristics of 74 clusters involving 183 cases (2-6 cases/cluster). Among 12 clusters of single intracluster transmission cases, 15 case-patients were infected within 5.5 days of the mean interval between illness onset of the infector and illness onset of the infectee. Among 56 clusters of single coexposure cases, the mean interval of symptom onset between the primary and second case-patient within a cluster was 3.1 days, and the mean interval of symptom onset between the primary and last case-patient within a cluster was 3.6 days (Appendix Table 2 ).

With continuous implementation of strict control measures, we observed a shortened span (median days declining from 3 to 1; p<0.001) between illness onset and hospital visits for case-patients (Table 1) . This finding may result from strict infection control management (e.g., early screening for suspected cases, monitoring for close-contact persons, and improved health consciousness of the general population).

To control the infection, confirmed case-patients should be separated and managed centrally; thus, the government has designated special hospitals to admit patients with suspected or confirmed cases. Nevertheless, as of February 5, to our knowledge, 1 case of a healthcare worker having been infected has been reported; an emergency nurse from a nondesignated hospital became ill on January 26, 2020, a total of 8 days after having been in close contact with a confirmed case-patient in the outpatient setting. We found that only 13%-15% of patients with confirmed cases went to the designated hospital first during the epidemic period. This finding means that a substantial number of case-patients visited >1 nondesignated hospital before they were admitted to the designated hospital, which increases the risk for nosocomial infection.

Essential for the control of this extremely contagious disease are close monitoring and timely reporting of the epidemic to the public as well as evaluation of the current control strategy. On the basis of this epidemiologic analysis, we found that COVID-19 has become endemic to Shenzhen, China. We suspect that community transmission and intrafamily transmission have potentially become the new transmission modes in the city. Also, nosocomial infection and transmission might pose a potential risk for COVID-19 control.

To control this outbreak in Shenzhen, maintaining basic and essential strategies is crucial. Early screening, diagnosis, isolation, and treatment are necessary to prevent further spread (7) . Throughout the city, management of persons in close contact with persons with diagnosed and suspected cases, restriction of public activity, and use of personal protection measures should be continued. Strengthening effective and efficient measures, including but not limited to personal protection within families and communities with a high risk for exposure, will prevent and interrupt community and intrafamily transmission. To prevent nosocomial infection and transmission, a 1322

Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 6, June 2020 

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. NEJM

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

What to do next to control the 2019-nCoV epidemic?

We acknowledge the work and contribution of all health providers from Shenzhen Third People's Hospital and Shenzhen Center for Disease Control and Prevention in the detection, treatment, and control of the outbreak. We also acknowledge Zhiqiang Yao for his review of the manuscript.